NCT06968169 The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
| NCT ID | NCT06968169 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Father Flanagan's Boys' Home |
| Condition | Developmental Language Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-02-09 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-02-09 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary.
Eligibility Criteria
Inclusion Criteria: * Has DLD or typical language development Exclusion Criteria * Has not been exposed to English since birth * Has other neurodevelopmental or sensory condition that could explain the language problem (e.g., intellectual disability, autism, hearing loss).
Contact & Investigator
Karla McGregor, Ph.D.
PRINCIPAL INVESTIGATOR
Boystown National Research Hospital
Frequently Asked Questions
Who can join the NCT06968169 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 10 Years, studying Developmental Language Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06968169 currently recruiting?
Yes, NCT06968169 is actively recruiting participants. Contact the research team at karla.mcgregor@boystown.org for enrollment information.
Where is the NCT06968169 trial being conducted?
This trial is being conducted at Omaha, United States.
Who is sponsoring the NCT06968169 clinical trial?
NCT06968169 is sponsored by Father Flanagan's Boys' Home. The principal investigator is Karla McGregor, Ph.D. at Boystown National Research Hospital. The trial plans to enroll 120 participants.